Berberine ameliorate oxidative stress and astrogliosis in the hippocampus of STZ-induced diabetic rats

Molecular Neurobiology

Volumn 49, Issue 2, 2014, Pages 820-826

  Moghaddam, Hamid Kalalian ^a   Baluchnejadmojarad, Tourandokht ^b   Roghani, Mehrdad ^c   Khaksari, Mehdi ^a   Norouzi, Pirasteh ^a   Ahooie, Malihea ^a   Mahboobi, Fatemeh ^a  

^a SHAHROUD UNIVERSITY OF MEDICAL SCIENCES   (Iran)

^b TEHRAN UNIVERSITY OF MEDICAL SCIENCES   (Iran)

^c SHAHED UNIVERSITY   (Iran)

Author keywords

Berberine; Diabetes; GFAP; Glial fibrillary acidic protein; Gliosis; Oxidative stress

Indexed keywords

BERBERINE; GLIAL FIBRILLARY ACIDIC PROTEIN; MALONALDEHYDE; NITRITE; SUPEROXIDE DISMUTASE;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ANTIOXIDANT ACTIVITY; ARTICLE; ASTROCYTE; ASTROCYTOSIS; CELL LEVEL; COGNITIVE DEFECT; CONTROLLED STUDY; DRUG EFFECT; ENZYME ACTIVITY; GLIA CELL; HIPPOCAMPUS; HYPERGLYCEMIA; IMMUNOHISTOCHEMISTRY; IMMUNOREACTIVITY; LIPID PEROXIDATION; MALE; NEUROPROTECTION; NONHUMAN; OXIDATIVE STRESS; RAT; STREPTOZOTOCIN-INDUCED DIABETES MELLITUS; UPREGULATION; ANIMAL; DIABETES MELLITUS, EXPERIMENTAL; DRUG EFFECTS; GLIOSIS; METABOLISM; PATHOLOGY; PHYSIOLOGY; WISTAR RAT;

ANIMALS; ASTROCYTES; BERBERINE; DIABETES MELLITUS, EXPERIMENTAL; GLIOSIS; HIPPOCAMPUS; MALE; OXIDATIVE STRESS; RATS; RATS, WISTAR;

EID: 84896070113     PISSN: 08937648     EISSN: 15591182     Source Type: Journal    
DOI: 10.1007/s12035-013-8559-7     Document Type: Article

References (52)

1. Northam EA et al (2009) Central nervous system function in youth with type 1 diabetes 12 years after disease onset. Diabetes Care 32: 445-450. doi:10.2337/Dc08-1657
2. Rains JL, Jain SK (2011) Oxidative stress, insulin signaling, and diabetes. Free Radic Biol Med 50:567-575. doi:10.1016/j.freeradbiomed.2010.12. 006
3. Russell JW et al (2008) Oxidative injury and neuropathy in diabetes and impaired glucose tolerance. Neurobiol Dis 30:420-429. doi:10.1016/j.nbd.2008.02. 013
4. Pitocco D et al (2010) Oxidative stress, nitric oxide, and diabetes. Rev Diabet Stud: RDS 7:15-25. doi:10.1900/RDS.2010.7.15
5. Pekny M, Pekna M (2004) Astrocyte intermediate filaments in CNS pathologies and regeneration. J Pathol 204:428-437. doi:10.1002/path.1645 (Pubitemid 39468154)
6. Rolo AP, Palmeira CM (2006) Diabetes and mitochondrial function: role of hyperglycemia and oxidative stress. Toxicol Appl Pharmacol 212:167-178. doi:10.1016/j.taap.2006.01.003
7. Hamby ME, Sofroniew MV (2010) Reactive astrocytes as therapeutic targets for CNS disorders. Neurotherapeutics 7:494-506. doi:10.1016/j.nurt.2010.07.003
8. Kimelberg HK, Nedergaard M (2010) Functions of astrocytes and their potential as therapeutic targets. Neurotherapeutics 7:338-353. doi:10.1016/j.nurt.2010.07.006
9. Baydas G et al (2003) Melatonin reduces glial reactivity in the hippocampus, cortex, and cerebellum of streptozotocin-induced diabetic rats. Free Radic Biol Med 35:797-804. doi:10.1016/S0891-5849(03)00408-8 (Pubitemid 37329483)
10. Pekny M, Wilhelmsson U, Bogestål YR, Pekna M (2007) In: Tiziana Corasaniti Giacinto Bagetta M, Lipton Stuart A (eds) International review of neurobiology, vol. 82. Academic, New York, pp 95-111
11. Middeldorp J, Hol EM (2011) GFAP in health and disease. Prog Neurobiol 93:421-443. doi:10.1016/j.pneurobio.2011.01.005
12. Coleman E, Judd R, Hoe L, Dennis J, Posner P (2004) Effects of diabetes mellitus on astrocyte GFAP and glutamate transporters in the CNS. Glia 48:166-178. doi:10.1002/glia.20068 (Pubitemid 39545948)
13. Imanshahidi M, Hosseinzadeh H (2008) Pharmacological and therapeutic effects of Berberis vulgaris and its active constituent, berberine. Phytother Res 22:999-1012. doi:10.1002/ptr.2399
14. Kulkarni SK, Dhir A(2008)On themechanismof antidepressant-like action of berberine chloride. Eur J Pharmacol 589:163-172. doi:10.1016/j.ejphar.2008.05. 043
15. Kulkarni SK, Dhir A (2010) Berberine: a plant alkaloid with therapeutic potential for central nervous system disorders. Phytother Res 24:317-324. doi:10.1002/Ptr.2968
16. Bhutada P et al (2011) Protection of cholinergic and antioxidant system contributes to the effect of berberine ameliorating memory dysfunction in rat model of streptozotocin-induced diabetes. Behav Brain Res 220:30-41. doi:10.1016/j.bbr.2011.01.022
17. Cok A et al (2011) Berberine acutely activates the glucose transport activity of GLUT1. Biochimie 93:1187-1192. doi:10.1016/j.biochi.2011.04.013
18. Gu Yet al (2010) Effect of traditional Chinese medicine berberine on type 2 diabetes based on comprehensive metabonomics. Talanta 81: 766-772. doi:10.1016/j.talanta.2010.01.015
19. Lee YS et al (2006) Berberine, a natural plant product, activates AMP-activated protein kinase with beneficial metabolic effects in diabetic and insulin-resistant states. Diabetes 55:2256-2264. doi:10.2337/Db06-0006 (Pubitemid 44743622)
20. Zhou JY et al (2009) Protective effect of berberine on beta cells in streptozotocin- and high-carbohydrate/high-fat diet-induced diabetic rats. Eur J Pharmacol 606:262-268. doi:10.1016/j.ejphar.2008.12.056
21. Kong WJ et al (2009) Berberine reduces insulin resistance through protein kinase C-dependent up-regulation of insulin receptor expression. Metabolism 58:109-119. doi:10.1016/j.metabol.2008.08.013
22. Huang L, Shi AD, He F, Li XS (2010) Synthesis, biological evaluation, and molecular modeling of berberine derivatives as potent acetylcholinesterase inhibitors. Bioorgan Med Chem 18:1244-1251. doi:10.1016/j.bmc.2009.12.035
23. Peng WH, Hsieh MT, Wu CR (1997) Effect of long-term administration of berberine on scopolamine-induced amnesia in rats. Jpn J Pharmacol 74:261-266
24. Zhu, F. Q., Qian, C. Y. (2006) Berberine chloride can ameliorate the spatial memory impairment and increase the expression of interleukin-1 beta and inducible nitric oxide synthase in the rat model of Alzheimer's disease. BMC Neurosci 7, doi:10.1186/1471-2202-7-78
25. Yoo JH et al (2006) Inhibitory effects of berberine against morphine-induced locomotor sensitization and analgesic tolerance in mice. Neuroscience 142:953-961. doi:10.1016/j.neuroscience.2006.07.008
26. Moghaddam HK, Baluchnejadmojarad T, Roghani M, Goshadrou F, Ronaghi A (2013) Berberine chloride improved synaptic plasticity in STZ induced diabetic rats. Metab Brain Dis. doi:10.1007/s11011-013-9411-5
27. Choi S-W, Benzie IFF, Ma S-W, Strain JJ, Hannigan BM (2008) Acute hyperglycemia and oxidative stress: direct cause and effect? Free Radic Biol Med 44:1217-1231. doi:10.1016/j.freeradbiomed. 2007.12.005
28. Edwards JL, Vincent AM, Cheng HT, Feldman EL (2008) Diabetic neuropathy: mechanisms to management. Pharmacol Ther 120:1-34. doi:10.1016/j.pharmthera. 2008.05.005
29. Orie NN, Zidek W, Tepel M (1999) Reactive oxygen species in essential hypertension and non-insulin-dependent diabetes mellitus. Am J Hypertens 12:1169-1174. doi:10.1016/S0895-7061(99)00129-6 (Pubitemid 30029278)
30. Hirao K et al (2010) Association of increased reactive oxygen species production with abdominal obesity in type 2 diabetes. Obes Res Clin Pract 4:e83-e90. doi:10.1016/j.orcp.2009.09.004
31. Steel JH et al (1994) Increased nitric oxide synthase immunoreactivity in rat dorsal root ganglia in a neuropathic pain model. Neurosci Lett 169:81-84. doi:10.1016/0304-3940(94)90361-1 (Pubitemid 24108868)
32. Sepici-Dincel A, Açikgöz Ş, Çevik C, Sengelen M, Yeşilada E (2007) Effects of in vivo antioxidant enzyme activities of myrtle oil in normoglycaemic and alloxan diabetic rabbits. J Ethnopharmacol 110:498-503. doi:10.1016/j.jep.2006.10.015 (Pubitemid 46394595)
33. Baydas G, Nedzvetskii VS, Tuzcu M, Yasar A, Kirichenko SV (2003) Increase of glial fibrillary acidic protein and S-100B in hippocampus and cortex of diabetic rats: effects of vitamin E. Eur J Pharmacol 462:67-71. doi:10.1016/S0014-2999(03)01294-9 (Pubitemid 36183736)
34. Kulkarni SK, Dhir A (2010) Berberine: a plant alkaloid with therapeutic potential for central nervous system disorders. Phytother Res: PTR 24:317-324. doi:10.1002/ptr.2968
35. Wang X et al (2005) Kinetic difference of berberine between hippocampus and plasma in rat after intravenous administration of Coptidis rhizoma extract. Life Sci 77:3058-3067. doi:10.1016/j.lfs.2005.02.033 (Pubitemid 41423743)
36. Zhou J-Y, Zhou S-W (2011) Protective effect of berberine on antioxidant enzymes and positive transcription elongation factor b expression in diabetic rat liver. Fitoterapia 82:184-189. doi:10.1016/j.fitote.2010.08.019
37. Yin J, Ye J, Jia W (2012) Effects and mechanisms of berberine in diabetes treatment. Acta PharmSin B 2:327-334. doi:10.1016/j.apsb.2012.06.003
38. Siow YL, Sarna L, Karmin O (2011) Redox regulation in health and disease - therapeutic potential of berberine. Food Res Int 44:2409-2417. doi:10.1016/j.foodres.2010.12.038
39. Tang L-Q, Wei W, Chen L-M, Liu S (2006) Effects of berberine on diabetes induced by alloxan and a high-fat/high-cholesterol diet in rats. J Ethnopharmacol 108:109-115. doi:10.1016/j.jep.2006.04.019 (Pubitemid 44498992)
40. Zhang Q et al (2011) Preventive effect of Coptis chinensis and berberine on intestinal injury in rats challenged with lipopolysaccharides. Food Chem Toxicol 49:61-69. doi:10.1016/j.fct.2010.09.032
41. Kalalian-Moghaddam H, Baluchnejadmojarad T, Roghani M, Goshadrou F, Ronaghi A (2013) Hippocampal synaptic plasticity restoration and anti-apoptotic effect underlie berberine improvement of learning and memory in streptozotocin-diabetic rats. Eur J Pharmacol 698:259-266. doi:10.1016/j.ejphar. 2012.10.020
42. Jahanshahi M, Golalipour MJ, Afshar M (2009) The effect of Urtica dioica extract on the number of astrocytes in the dentate gyrus of diabetic rats. Folia Morphol (Warsz) 68:93-97
43. Pekny M, Wilhelmsson U, Bogestal YR, Pekna M (2007) The role of astrocytes and complement system in neural plasticity. Int Rev Neurobiol 82:95-111. doi:10.1016/S0074-7742(07)82005-8
44. O'Callaghan JP, Sriram K (2005) Glial fibrillary acidic protein and related glial proteins as biomarkers of neurotoxicity. Expert Opin Drug Saf 4:433-442. doi:10.1517/14740338.4.3.433 (Pubitemid 40723718)
45. Fernandez-Fernandez S, Almeida A, Bolanos JP (2012) Antioxidant and bioenergetic coupling between neurons and astrocytes. Biochem J 443:3-11. doi:10.1042/BJ20111943
46. Dringen R, Gutterer JM, Hirrlinger J (2000) Glutathione metabolism in brain metabolic interaction between astrocytes and neurons in the defense against reactive oxygen species. Eur J Biochem / FEBS 267: 4912-4916
47. Yoo HJ et al (2008) Anti-inflammatory, anti-angiogenic and anti-nociceptive activities of Saururus chinensis extract. J Ethnopharmacol 120:282-286. doi:10.1016/j.jep.2008.08.016
48. Ingkaninan K, Phengpa P, Yuenyongsawad S, Khorana N (2006) Acetylcholinesterase inhibitors from Stephania venosa tuber. J Pharm Pharmacol 58:695-700. doi:10.1211/jpp.58.5.0015
49. Dhir A, Naidu PS, Kulkarni SK (2007) Neuroprotective effect of nimesulide, a preferential COX-2 inhibitor, against pentylenetetrazol (PTZ)-induced chemical kindling and associated biochemical parameters in mice. Seizure-Eur J Epilep 16:691-697. doi:10.1016/j.seizure.2007.05.016 (Pubitemid 350018665)
50. Lu DY, Tang CH, Chen YH, Wei IH (2010) Berberine suppresses neuroinflammatory responses through AMP-activated protein kinase activation in BV-2 microglia. J Cell Biochem 110:697-705. doi:10.1002/jcb.22580
51. Liu Q, Chen L, Hu L, Guo Y, Shen X (2010) Small molecules from natural sources, targeting signaling pathways in diabetes. Biochim Biophys Acta 1799:854-865. doi:10.1016/j.bbagrm.2010.06.004
52. Vannucci SJ, Maher F, Simpson IA (1997) Glucose transporter proteins in brain: delivery of glucose to neurons and glia. Glia 21:2-21 (Pubitemid 27389636)